Developing a urea biosensor and safe blood cleaning method utilizing a novel high throughput La-doped CeO nanosized artificial urease with high biocompatibility and enzyme-like activity.

Herein, a urea biosensor and safe blood cleaning method utilizing a novel high throughput La-doped CeO nanosized artificial urease with high biocompatibility and enzyme-like activity were developed. The urease-like activity, stability composition, morphological characteristics, size, biocompatibility, and crystalline characteristics of the artificial urease were assessed. Considering its high urease-like activity, it is applied for both urea biosensing and safe blood cleaning.

Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis.

Background: Chronic obstructive pulmonary disease (COPD) significantly impacts global health due to persistent airflow limitation and inflammation. Despite standard therapies, symptoms persist. Ensifentrine, targeting both bronchoconstriction and inflammation as a dual phosphodiesterase 3 and 4 inhibitor, offers a promising therapeutic advancement for COPD management.